| pubmed-article:9731087 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9731087 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:9731087 | lifeskim:mentions | umls-concept:C2004489 | lld:lifeskim |
| pubmed-article:9731087 | lifeskim:mentions | umls-concept:C0003620 | lld:lifeskim |
| pubmed-article:9731087 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:9731087 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:9731087 | pubmed:dateCreated | 1998-9-15 | lld:pubmed |
| pubmed-article:9731087 | pubmed:abstractText | Recent case reports suggest that a combination of the appetite suppressants fenfluramine and phentermine is associated with an increased risk of cardiac-valve regurgitation. There are also reports of valvular disorders in persons taking fenfluramine or dexfenfluramine alone, particularly for more than three months. | lld:pubmed |
| pubmed-article:9731087 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9731087 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9731087 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9731087 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9731087 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9731087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9731087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9731087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9731087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9731087 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9731087 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:9731087 | pubmed:issn | 0028-4793 | lld:pubmed |
| pubmed-article:9731087 | pubmed:author | pubmed-author:JickHH | lld:pubmed |
| pubmed-article:9731087 | pubmed:author | pubmed-author:MeierC RCR | lld:pubmed |
| pubmed-article:9731087 | pubmed:author | pubmed-author:WeinrauchL... | lld:pubmed |
| pubmed-article:9731087 | pubmed:author | pubmed-author:JickS SSS | lld:pubmed |
| pubmed-article:9731087 | pubmed:author | pubmed-author:DerbyL ELE | lld:pubmed |
| pubmed-article:9731087 | pubmed:author | pubmed-author:VasilakisCC | lld:pubmed |
| pubmed-article:9731087 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9731087 | pubmed:day | 10 | lld:pubmed |
| pubmed-article:9731087 | pubmed:volume | 339 | lld:pubmed |
| pubmed-article:9731087 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9731087 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9731087 | pubmed:pagination | 719-24 | lld:pubmed |
| pubmed-article:9731087 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:meshHeading | pubmed-meshheading:9731087-... | lld:pubmed |
| pubmed-article:9731087 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9731087 | pubmed:articleTitle | A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation. | lld:pubmed |
| pubmed-article:9731087 | pubmed:affiliation | Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, MA 02421, USA. | lld:pubmed |
| pubmed-article:9731087 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9731087 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9731087 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9731087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9731087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9731087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9731087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9731087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9731087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9731087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9731087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9731087 | lld:pubmed |
